InnotiveDx gets £1m grant to advance UTI diagnostics system
November 27, 2025Research and Development Diagnostics, InnotiveDx, Urology
InnotiveDx has announced that it has received a £1m grant from Pathways to Antimicrobial Clinical Efficacy (PACE) to advance the …
Cellbyte raises $2.75m to fund pharma drug launch platform
November 27, 2025Product launch AI, Cellbyte, biotech
Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of pharmaceutical drug launches. The complexity …
Accession Therapeutics doses first patient in new cancer immunotherapy trial
November 26, 2025Research and Development Accession Therapeutics, Oncology
Biopharmaceutical company Accession Therapeutics has announced the dosing of the first patient in the phase 1 clinical trial of TROCEPT-01 …
ViVac Pharma appoints Keren Leshem as CEO
November 26, 2025CEO, Oncology, ViVac Pharma
Early-stage biotechnology company ViVac Pharma has appointed Keren Leshem as its new CEO. Leshem brings almost 30 years of experience …
Alvotech biosimilar receives EC marketing approval
November 26, 2025Research and Development Alvotech, Immunology, Inflammatory disease, Rheumatology
The European Commission (EC) has granted marketing authorisation for Gobivaz, Alvotech’s first-in-market biosimilar of Simponi (golimumab), which is used for …
A community-first future: which pathways will get us there?
November 21, 2025Business Services Gateway to Local Adoption, NHS, Visions4Health, pharmacy
In the final Gateway to Local Adoption article of 2025, Visions4Health caught up with Julian Wenman, senior operations manager in …
Scitech Engineering joins Ekium Group, rebrands as Scitech-EKIUM
November 21, 2025Manufacturing and Production Ekium Group, Engineering, Good Manufacturing Production, Scitech Engineering, automation
Scitech Engineering, a provider of engineering and manufacturing services across multiple industries including life sciences, has joined the Ekium Group, …
M42 and Olive Rock agree ownership of UAE health assets
November 20, 2025Business Services M42, Olive Rock, UAE health assets
Global health company M42 and private equity firm Olive Rock Partners (ORP) have signed an agreement that will see the …
iZafe Group signs agreement with Skand for automated medication dispenser
November 20, 2025Business Services Skand, iZafe Group
iZafe Group have signed a distribution agreement with Skand for the launch of Dosell, a medication-dispensing robot, in Iceland. Dosell …
BioNet receives positive EMA opinion on new pertussis vaccine
November 19, 2025Research and Development BioNet, Vaccine
BioNet has received a positive opinion from the Committee for Medicinal Products for Human Use of the European Medicines Agency …
1nhaler receives £1.5m in funding to develop new cardboard inhaler
November 19, 2025Research and Development 1nhaler, asthma
1nhaler, a Scotland-based developer of drug delivery devices, has received £1.5m in seed funding for the development of its new …
Molnlycke donates risk prediction patent to SKF’s digital patent platform
November 14, 2025Business Services Digital Platforms, Mölnlycke, SKF, The Patent Bay
Mölnlycke Health Care, a medtech company specialising in wound care and surgical solutions, has donated a risk prediction patent to …
Study finds at-home brain stimulation therapies reduce depression relapse rate
November 14, 2025Research and Development Brain Stimulation Therapies, Flow Neuroscience, Transcranial Direct Current Stimulation Therapy, depression
A new study published in the Journal of Affective Disorders has found that home-based, transcranial, direct current stimulation (tDCS) therapy, …
Smurfit Westrock unveils new clinical packaging facility at Dublin Airport
November 13, 2025Medical Communications Dublin, Smurfit Westrock, clinical packaging facility
Smurfit Westrock has inaugurated the first-of-its-kind adherence and clinical packaging facility, reinforcing Ireland’s role at the forefront of global healthcare. …
EVerZom enters research and licensing agreement with GENFIT
November 13, 2025Research and Development EVerZom, Eviv, GENFIT, Liver Diseases, collaboration, licensing agreement
EVerZom, a French biotech company developing exosome-based therapies for regenerative medicine, has entered into a research and licensing agreement with …
University of Birmingham scientists develop new MRI contrast agent
November 12, 2025Research and Development Diagnostics, MRI, University of Birmingham, medical imaging
Researchers at the University of Birmingham, UK, have developed a new class of magnetic resonance imaging (MRI) contrast agents that …
Custom Pharmaceuticals launches new company for drug product development
November 12, 2025Business Services Centrix Pharma Solutions, Company Launch, Custom Pharmaceuticals, collaboration, drug development, university of sussex
Customs Pharmaceuticals, a full-service contract development and manufacturing organisation (CDMO), has launched Centrix Pharma Solutions, a new company targeting faster …
Novartis receives SMC approval for early breast cancer treatment
November 11, 2025Research and Development Novartis, Scottish Medicines Consortium, breast cancer, nhs scotland
Novartis has announced that its treatment for early breast cancer, Kisqali (ribociclib), has received approval for use within NHS Scotland …
Chiesi expands La Chaussée-Saint-Victor site to manufacture next-gen inhalers
November 10, 2025Manufacturing and Production Chiesi, Metered Dose Inhalers, Site Expansion, respiratory diseases
Chiesi, a biopharma group focused on treating respiratory diseases, has inaugurated an expansion of its manufacturing and industrial site in …
Richmond Pharmacology appoints Dr Edward Jackson as Medical Director
November 7, 2025CRO, Richmond Pharmacology, biotech, clinical trials
Richmond Pharmacology, a contract research organisation (CRO) specialising in first-in-human and adaptive clinical trials, has appointed Dr Edward Jackson as …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
